DK137392C - Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination - Google Patents

Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination

Info

Publication number
DK137392C
DK137392C DK447972A DK447972A DK137392C DK 137392 C DK137392 C DK 137392C DK 447972 A DK447972 A DK 447972A DK 447972 A DK447972 A DK 447972A DK 137392 C DK137392 C DK 137392C
Authority
DK
Denmark
Prior art keywords
prevaccination
vira
copd
vaccinia
vaccination
Prior art date
Application number
DK447972A
Other languages
Danish (da)
English (en)
Other versions
DK137392B (da
Inventor
A H Stickl
Original Assignee
Bayern Freistaat
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19712145477 external-priority patent/DE2145477C3/de
Application filed by Bayern Freistaat filed Critical Bayern Freistaat
Publication of DK137392B publication Critical patent/DK137392B/da
Application granted granted Critical
Publication of DK137392C publication Critical patent/DK137392C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/275—Poxviridae, e.g. avipoxvirus
    • A61K39/285—Vaccinia virus or variola virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK447972A 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination DK137392C (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19712145477 DE2145477C3 (de) 1971-09-11 Impfstoff für die intracutane Pockenschutzimpfung

Publications (2)

Publication Number Publication Date
DK137392B DK137392B (da) 1978-02-27
DK137392C true DK137392C (da) 1978-09-18

Family

ID=5819271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK447972A DK137392C (da) 1971-09-11 1972-09-11 Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination

Country Status (5)

Country Link
AT (1) AT320149B (2)
BE (1) BE787901A (2)
CH (1) CH568392A5 (2)
DK (1) DK137392C (2)
ES (1) ES406590A1 (2)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2714665A1 (de) * 1977-04-01 1978-10-05 Mayr Anton Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung
JPS60202827A (ja) * 1984-03-28 1985-10-14 Chibaken 弱毒痘そうワクチン株
CA1341245C (en) * 1988-01-12 2001-06-05 F. Hoffmann-La Roche Ag Recombinant vaccinia virus mva
UA68327C2 (en) 1995-07-04 2004-08-16 Gsf Forschungszentrum Fur Unwe A recombinant mva virus, an isolated eukaryotic cell, infected with recombinant mva virus, a method for production in vitro of polypeptides with use of said cell, a method for production in vitro of virus parts (variants), vaccine containing the recombinant mva virus, a method for immunization of animals
WO2004015118A1 (en) 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
EP2363143A3 (en) 2003-03-28 2012-02-15 The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services MVA expressing modified hiv envelope, gag, and pol genes
US9453239B2 (en) 2004-08-27 2016-09-27 Emory University Recombinant MVA viruses expressing clade A/G, clade B, and clade C modified HIV env, gag and pol genes
JP2010526546A (ja) 2007-05-14 2010-08-05 バヴァリアン・ノルディック・アクティーゼルスカブ ワクシニアウイルス系及び組換えワクシニアウイルス系ワクチンの精製
AU2010305030A1 (en) 2009-10-08 2012-05-10 Bavarian Nordic A/S Generation of a broad T-cell response in humans against HIV
JP5945270B2 (ja) 2010-07-20 2016-07-05 バヴァリアン・ノルディック・アクティーゼルスカブ 発現産物を採取するための方法
EP2620446A1 (en) 2012-01-27 2013-07-31 Laboratorios Del Dr. Esteve, S.A. Immunogens for HIV vaccination
DE102013004595A1 (de) 2013-03-15 2014-09-18 Emergent Product Development Germany Gmbh RSV-Impfstoffe
WO2017120577A1 (en) 2016-01-08 2017-07-13 Geovax Inc. Compositions and methods for generating an immune response to a tumor associated antigen
TWI810456B (zh) 2019-05-22 2023-08-01 美商基利科學股份有限公司 Tlr7調節化合物及hiv疫苗之組合
AU2020384323A1 (en) 2019-11-14 2022-06-02 Aelix Therapeutics, S.L. Dosage regimens for vaccines
EP4103231A4 (en) 2020-02-14 2024-03-27 Geovax, Inc. VACCINES AND THEIR USES TO INDUCE AN IMMUNE RESPONSE AGAINST SARS-COV2
WO2021260065A1 (en) 2020-06-24 2021-12-30 Consejo Superior De Investigaciones Científicas (Csic) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP3928789A1 (en) 2020-06-24 2021-12-29 Consejo Superior de Investigaciones Científicas (CSIC) Mva-based vaccine against covid-19 expressing sars-cov-2 antigens
EP4358999A1 (en) 2021-06-23 2024-05-01 Consejo Superior De Investigaciones Científicas Mva-based vaccine expressing a prefusion-stabilized sars-cov-2 s protein
EP4108257A1 (en) 2021-06-23 2022-12-28 Consejo Superior De Investigaciones Científicas Mva-based vaccine against covid-19 expressing a prefusion-stabilized sars-cov-2 s protein

Also Published As

Publication number Publication date
BE787901A (fr) 1972-12-18
DE2145477A1 (de) 1973-03-15
ES406590A1 (es) 1975-09-16
DK137392B (da) 1978-02-27
DE2145477B2 (de) 1976-04-01
CH568392A5 (2) 1975-10-31
AT320149B (de) 1975-01-27

Similar Documents

Publication Publication Date Title
DK137392C (da) Fremgangsmaade til fremstilling af en koppebeskyttelsesvaccinei form af svaekket vaccinia-vira,til brug ved forvaccination inden den egentlige koppevaccination
DK114429B (da) Fremsgangmåde til fremstilling af et med kontrolleret frigørelse virkende terapeutisk præparat til oral brug.
DK131891C (da) Fremgangsmade til fremstilling af et pulverpreparat til inhalation
DK145283C (da) Vaccine til forhindring af graviditet og fremgangsmaade til fremstilling af vaccinen
DK132321C (da) Analogifremgangsmade til fremstilling af usymmetriske 1,4-dihydropyridiner
DK138695C (da) Fremgangsmaade til fremstilling af pyrrolidon-5,5-difosfonsyrer og vandoploeselige salte heraf
SE7604818L (sv) Vaccin
AR193737A1 (es) Composicion glaseadora a base de fluoruro para esmalte dental
DK143437C (da) Fremgangsmaade til fremstilling af en vaccine til hindring af sygdomme fremkaldt af katteleukaemivirus
DK135040C (da) Fremgangsmade til fremstilling af 2-amino-1,4-dihydropyridiner
NL7607958A (nl) Nieuw rabies virusvaccin en werkwijze ter bereiding daarvan.
BE794307A (fr) Vaccin anti-caries
BE781028R (fr) Adjuvants pour vaccins et preparations de vaccins les
DK114644B (da) Fremgangsmåde til fremstilling af antigeniske, ikke-toksiske influenzavirusunderenhedsvacciner.
TR16871A (tr) Ikis cesit yanisli emuelsiyonlu brueloerlerin isletilmesine mahsus usul
IT966747B (it) Procedimento per preparare dinitroantrachinoni
DK132447C (da) Fremgangsmade til fremstilling af kalvediarrevirusvaccine
DK139521C (da) Fremgangsmaade til fremstilling af ren krystallinsk penicillinacylase
DK119939B (da) Fremgangsmåde til fremstilling af tetanus-vaccine.
DK129590B (da) Fremgangsmåde til fremstilling af levende vaccine mod infektiøs bursitis hos høns.
DK132221C (da) Fremgangsmade til fremstilling af 2,4-diamino-5-benzylpyrimidiner
DK141055C (da) Fremgangsmaade til fremstilling af en intravenoest acceptabel vaccine mod hundesyge og hepatitis contagiosa canis
DK137118B (da) Fremgangsmade til fremstilling af et lh-rh-preparat til nasal applikation
SE424503B (sv) Forfarande for framstellning av levande influensavirusvaccin typ b
DK146312C (da) Fremgangsmaade til fremstilling af en vaccine mod neonatal diarre